KRYSTAL UMFLEET: Open Payments
NPI 1679931968 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,460 in 137 payments from 21 companies in 2025. Trend: 2023 $2,716 · 2024 $3,125 · 2025 $2,460
Food & beverage: $2,460
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $457 |
| ABBVIE INC. | 30 | $438 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $256 |
| Janssen Biotech, Inc. | 8 | $248 |
| Gilead Sciences, Inc. | 5 | $135 |
| Ardelyx, Inc. | 6 | $133 |
| QOL Medical, LLC | 6 | $124 |
| PFIZER INC. | 4 | $96 |
| Phathom Pharmaceuticals, Inc. | 5 | $92 |
| Madrigal Pharmaceuticals | 6 | $88 |
Products named: ENTYVIO, XIFAXAN, TREMFYA, IBSRELA, SKYRIZI, Sucraid, RINVOQ, Livdelzi.
Industry payments across OH — which companies pay providers there.
